Market Overview
Installed mix and capacity gaps
- Brevintel analysis values the market at USD 63.6 billion in 2025 ($63.6B) and USD 67.3 billion in 2026, expanding to USD 108.1 billion by 2035 ($108.1B) at a 5.4% CAGR.
- The mix includes defibrillators, multiparameter monitors, ECG devices, dialysis and CRRT systems, infusion pumps, ventilators, feeding tubes, and anesthesia monitors.
- Medtronic plc led with over 11% market share in 2025; the top five held 45%.
- OECD countries averaged 16.9 ICU beds per 100,000 people in 2021, while high-income countries averaged 12.79 beds versus 2.05 in lower-middle-income countries.
- Asia-Pacific critical-care bed availability increased from 3.0 to 9.4 beds per 100,000 people between 2017 and 2022 across 19 studied countries and regions.
- North America accounted for USD 23.8 billion, or 37.5%, of 2025 demand; Europe USD 16.9 billion; Asia Pacific USD 16.0 billion.
- The 5.4% forecast reflects equipment-mix change rather than a simple expansion in bed count.
- New ICU capacity requires foundational monitoring, infusion, ventilation, and renal-support equipment, while mature providers replace stand-alone hardware with interoperable platforms.
Market Dynamics
Disease burden and constraints
- Cardiovascular disease drove 19.2 million deaths in 2023, with 626 million people living with the condition.
- Chronic kidney disease affected 788 million adults globally in 2023.
- COPD was the third leading cause of death globally in 2023, causing 3.4 million deaths.
- The global nursing shortage stood at 5.8 million in 2023; low-resource ICUs have reported nurse-to-patient ratios of 1:4 or worse versus recommended 1:1 or 1:2.
- Philips' July 2025 SDC partnership with Drager, Hamilton Medical, Getinge, and B. Braun supports bidirectional device data exchange.
- U.S. COPD prevalence, with approximately 11.1 million diagnosed adults in 2023, reinforces respiratory-care demand.
- CRRT cost, including recurring filters, circuits, and solutions, has been identified as an adoption barrier in developing settings.
- Getinge reported ventilator demand as a growth contributor in Acute Care Therapies during 2025.
Segmentation Analysis
Product type
- Defibrillators generated USD 14.8 billion in 2025, equal to 23.3% of market revenue, and are forecast at a 6.1% CAGR.
- Multiparameter monitors represented USD 11.1 billion and are expected to grow at a 6.2% CAGR.
- ECG devices accounted for USD 8.0 billion and are comparatively mature, with a 3.8% CAGR.
- Hemodialysis machines represented USD 6.7 billion, while infusion pumps generated USD 6.8 billion.
- Ventilators represented USD 4.7 billion and are projected to grow at a 6.7% CAGR.
- Feeding tubes accounted for USD 2.9 billion, anesthesia monitors USD 1.6 billion, CRRT machines USD 1.5 billion, and other products USD 5.4 billion in 2025.
- CRRT's 7.8% CAGR reflects use in hemodynamically unstable patients with acute kidney injury.
- ICU Medical received FDA clearances in April 2025 for Plum Solo and Plum Duo pumps with stated ±3% delivery accuracy.
Application and end use
- Cardiology was the largest application at approximately USD 22.7 billion, or 35.7% of 2025 revenue.
- Renal care generated USD 14.6 billion and is forecast to grow at a 6.8% CAGR.
- Neurology accounted for USD 7.8 billion and is expected to expand at a 6.2% CAGR.
- Hospitals accounted for approximately USD 27.4 billion, or 43.1%, of 2025 revenue.
- Ambulatory surgical centers are projected to grow at a 6.2% CAGR, and specialty clinics at a 5.8% CAGR.
Regional Outlook
Geographic demand
- North America generated USD 23.8 billion in 2025 and held 37.5% share, with approximately 5.0% CAGR projected through 2035.
- The U.S. market advanced from USD 19.1 billion in 2022 to USD 22.2 billion in 2025.
- Europe represented USD 16.9 billion in 2025, or approximately 26.5% of global revenue, and is projected to grow at roughly 5.1% CAGR.
- Germany's ICU capacity was approximately 33.9 beds per 100,000 population.
- Asia Pacific reached approximately USD 16.0 billion in 2025 and is projected to grow at a 6.2% CAGR, the fastest pace among major regions.
- India had 10.9 critical-care beds per 100,000 people, Japan 10.7, and South Korea 17.6.
- Latin America generated approximately USD 4.6 billion in 2025 at about 5.7% CAGR; Middle East and Africa totaled about USD 2.3 billion at about 5.3% CAGR.
- Saudi Arabia's reported ICU capacity of 21.7 beds per 100,000 people indicates relatively developed infrastructure within MEA.
Competitive Landscape
Structure
- Medtronic, Koninklijke Philips, GE Healthcare, Dragerwerk, and Becton Dickinson collectively accounted for approximately 45% of global revenue.
- Medtronic reported FY2024 revenue of USD 32.364 billion, including USD 1.908 billion from Acute Care & Monitoring, and received FDA approval for the OmniaSecure lead in April 2025.
- Becton, Dickinson and Company completed its USD 4.2 billion acquisition of Edwards Lifesciences' Critical Care business in September 2024.
- Fresenius Medical Care served approximately 299,000 dialysis patients through 3,675 clinics and reported approximately 50% global hemodialysis-product market share.
- Abbott Laboratories reported USD 44.33 billion in annual revenue; Boston Scientific reported USD 19.5 billion in 2024 revenue.
- Getinge derived more than half of 2024 group sales from Acute Care Therapies and extended Servo-c ventilation to neonatal patients weighing as little as 500 grams.
Integrated producers
- Medtronic plc
- Koninklijke Philips N.V.
- GE Healthcare
- Becton, Dickinson and Company (BD)
Specialty suppliers
- Getinge
- Hamilton Medical
- ICU Medical
- Fresenius Medical Care